(最終更新日:2024-10-08 13:45:16)
  ホリタニ ケイタ   HORITANI KEITA
  堀谷 啓太
   所属   関西医科大学  内科学第二講座
   職種   助教
■ 学術雑誌掲載論文
1. 原著(症例報告除く)  Influence of Postprandial Hyperglycemia and Hypertriglyceridemia: A Focus on Endothelial Progenitor Cells and Bone Marrow Stem/Progenitor Cell Senescence 2024/09
2. 原著(症例報告除く)  Disruption of the Uty epigenetic regulator locus in hematopoietic cells phenocopies the profibrotic attributes of Y chromosome loss in heart failure 2024/03
3. 原著(症例報告除く)  Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction 2023/10
4. 原著(症例報告除く)  Wnt5a-YAP signaling axis mediates mechanotransduction in cardiac myocytes and contributes to contractile dysfunction induced by pressure overload 2023/06
5. 総説  Somatic Mosaicism in Biology and Disease 2022/02
全件表示(8件)
■ 学会発表
1. Empagliflozin's Cardioprotective Role through Modulation of CCL2 Expression in Cardiac Fibroblasts, Attenuation of Inflammation, and Mitigation of Heart Failure Progression. (ポスター掲示,一般) 2024/03/10
2. 肺静脈閉塞症(PVOD)を合併した3型肺高血圧患者に対する薬剤調整に難渋した一例 (口頭,一般) 2023/09/02
3. Empagliflozin protects against heart failure through inhibition of inflammatory responses mediated by bone marrow-derived Macrophages in mice. (口頭,一般) 2023/07/13
4. SGLT2 inhibitor Empagliflozin protects against heart failure through inhibition of inflammatory responses mediated by bone marrow-derived immune cells in mice. (ポスター掲示,一般) 2023/03/11
5. SGLT2 inhibitor Empagliflozin protects against heart failure through inhibition of inflammatory responses mediated by bone marrow-derived immune cells in mice. (口頭,一般) 2022/12/16
全件表示(19件)